Literature DB >> 15247149

Nicotine and fibronectin expression in lung fibroblasts: implications for tobacco-related lung tissue remodeling.

Jesse Roman1, Jeffrey D Ritzenthaler, Alcides Gil-Acosta, Hilda N Rivera, Susanne Roser-Page.   

Abstract

Tobacco-related lung diseases are associated with alterations in tissue remodeling and are characterized by increased matrix deposition. Among the matrix molecules found to be highly expressed in tobacco-related lung diseases is fibronectin, a cell adhesive glycoprotein implicated in tissue injury and repair. We hypothesize that nicotine, a component of tobacco, stimulates the expression of fibronectin in lung fibroblasts via the activation of intracellular signals that lead to increased fibronectin gene transcription. In support of this, we found that nicotine stimulated the expression of fibronectin in lung fibroblasts and that its stimulatory effect was associated with activation of protein kinase C and mitogen-activated protein kinases, increased levels of intracellular cAMP, and phosphorylation and DNA binding of the transcription factor CREB. Increased transcription of the gene was dependent on cAMP-response elements (CREs) present on the 5' end of its gene promoter. The stimulatory effect of nicotine on fibronectin expression was abolished by alpha-bungarotoxin, an inhibitor of alpha7 nicotinic acetylcholine receptors (alpha7 AChRs). Of note, nicotine increased the expression of alpha7 nAChRs on fibroblasts. Our data suggest that nicotine induces lung fibroblasts to produce fibronectin by stimulating alpha7 nAChR-dependent signals that regulate the transcription of the fibronectin gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247149     DOI: 10.1096/fj.03-0826fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  38 in total

1.  Perinatal nicotine exposure suppresses PPARγ epigenetically in lung alveolar interstitial fibroblasts.

Authors:  M Gong; J Liu; R Sakurai; A Corre; S Anthony; V K Rehan
Journal:  Mol Genet Metab       Date:  2015-01-29       Impact factor: 4.797

Review 2.  Alterations in Cholinergic Pathways and Therapeutic Strategies Targeting Cholinergic System after Traumatic Brain Injury.

Authors:  Samuel S Shin; C Edward Dixon
Journal:  J Neurotrauma       Date:  2015-06-29       Impact factor: 5.269

3.  COX-2-derived prostaglandins as mediators of the deleterious effects of nicotine in chronic kidney disease.

Authors:  S Rangarajan; G Rezonzew; P Chumley; H Fatima; M Y Golovko; W Feng; P Hua; E A Jaimes
Journal:  Am J Physiol Renal Physiol       Date:  2019-12-16

4.  Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers.

Authors:  Ping Hua; Wenguang Feng; Shaonin Ji; Leopoldo Raij; Edgar A Jaimes
Journal:  Am J Physiol Renal Physiol       Date:  2010-08-04

5.  Duplicated copy of CHRNA7 increases risk and worsens prognosis of COPD and lung cancer.

Authors:  Lei Yang; Xiaoxiao Lu; Fuman Qiu; Wenxiang Fang; Lisha Zhang; Dongsheng Huang; Chenli Xie; Nanshan Zhong; Pixin Ran; Yifeng Zhou; Jiachun Lu
Journal:  Eur J Hum Genet       Date:  2014-11-19       Impact factor: 4.246

6.  PPARγ agonist rosiglitazone prevents perinatal nicotine exposure-induced asthma in rat offspring.

Authors:  Jie Liu; Reiko Sakurai; E M O'Roark; Nicholas J Kenyon; John S Torday; Virender K Rehan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-02-25       Impact factor: 5.464

7.  alpha5beta1-integrin expression is essential for tumor progression in experimental lung cancer.

Authors:  Jesse Roman; Jeffrey D Ritzenthaler; Sussane Roser-Page; XiaoJuan Sun; ShouWei Han
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-15       Impact factor: 6.914

8.  Nicotinic acetylcholine receptors are sensors for ethanol in lung fibroblasts.

Authors:  Jeffrey D Ritzenthaler; Susanne Roser-Page; David M Guidot; Jesse Roman
Journal:  Alcohol Clin Exp Res       Date:  2013-02-19       Impact factor: 3.455

9.  Nicotine stimulates PPARbeta/delta expression in human lung carcinoma cells through activation of PI3K/mTOR and suppression of AP-2alpha.

Authors:  XiaoJuan Sun; Jeffrey D Ritzenthaler; XiaoRong Zhong; Ying Zheng; Jesse Roman; ShouWei Han
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

Review 10.  The effects of smoking on the developing lung: insights from a biologic model for lung development, homeostasis, and repair.

Authors:  Virender K Rehan; Kamlesh Asotra; John S Torday
Journal:  Lung       Date:  2009-07-30       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.